Alzheimer’s disease is currently the sixth leading cause of death in the United States. While recent data indicate nearly six million Americans currently live with the disease, some estimates suggest that number could triple by 2060, causing yearly treatment costs in the hundreds of billions of dollars.Â
What innovations show the most promise for early detection and treatment for this disease that takes a crushing toll on patients, their loved ones and caregivers? How are researchers and doctors better understanding risk factors and diagnoses? How can underserved groups be given equitable access to care, education, and clinical trials? And how can policies prioritize research, awareness, detection and treatment?
On March 2, The Hill sits down with policymakers, physicians, caregivers, patient advocates and experts to explore the fight against Alzheimer’s while offering a glimpse into the promise for the road ahead.
